Initiator Pharma A/S
Records under this name other than the patents Initiator Pharma A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 2 of 2 · Back to Initiator Pharma A/S
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,696,350 | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Term ended Term ended Jul 4, 2026 · USPTO record | Term ended | Term ended Jul 4, 2026 | USPTO record |
| US 8,697,721 | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Lapsed on the fee record Ended Apr 15, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 15, 2026 | USPTO record |